Home » Stocks » BNGO

BioNano Genomics, Inc. (BNGO)

Stock Price: $5.41 USD 0.10 (1.88%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $5.45 +0.04 (0.74%) May 7, 7:59 PM
Market Cap 1.51B
Revenue (ttm) 8.50M
Net Income (ttm) -41.11M
Shares Out 104.25M
EPS (ttm) -0.39
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $5.41
Previous Close $5.31
Change ($) 0.10
Change (%) 1.88%
Day's Open 5.42
Day's Range 5.32 - 5.73
Day's Volume 16,195,466
52-Week Range 0.35 - 15.69

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

The science underlining BNGO stock is incredibly compelling. But that's not what the market actually cares about right now.

5 days ago - InvestorPlace

It's hard to reconcile the sell-off in BNGO stock with Bionano's progress in advancing the Saphyr system - but this presents an opportunity. The post Bionano Genomics Has Disappointed, but Its NHS Deal ...

1 week ago - InvestorPlace

Bionano Genomics, Inc. (BNGO) closed the most recent trading day at $6.97, moving -1.13% from the previous trading session.

1 week ago - Zacks Investment Research

Cyclerion Therapeutics, Inc. (NASDAQ: CYCN), Sol-Gel Technologies Ltd. (NASDAQ: SLGL), Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), DermTech, Inc. (NASDAQ: DMTK) and Bionano Genomics, Inc. (NASDAQ: BNGO) ...

Other stocks mentioned: DMTK
1 week ago - Benzinga

The bulls are on parade.

Other stocks mentioned: NAKD, OCGN, ZOM, CTRM
1 week ago - The Motley Fool

BioNano Genomics Inc (NASDAQ:BNGO) shares are trading higher by 19.5% at $7.36 Monday on continued strength following last week's publication of DNA replication data, a fundamental process of cell growt...

1 week ago - Benzinga

Bionano's deal with the UK leaves the company well-positioned to make deals with many nations. Investors should buy BNGO stock.

2 weeks ago - InvestorPlace

Can you count on this company's novel gene diagnostic technology?

2 weeks ago - The Motley Fool

Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wednesday. Ocugen is moving after its partner Bharat Biotech announced positive study results, and Biona...

Other stocks mentioned: OCGN
2 weeks ago - Benzinga

Bionano Genomics, Inc. (NASDAQ: BNGO) and Ocugen, Inc. (NASDAQ: OCGN) were among the early movers among biopharma stocks. Bionano Gains On Adoption of Genomic Mapping System By U.K. Labs: Bionano said i...

Other stocks mentioned: OCGN
2 weeks ago - Benzinga

This stock market mover's growth story is just beginning.

2 weeks ago - The Motley Fool

No news; just run-of-the-mill volatility.

3 weeks ago - The Motley Fool

BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment.

4 weeks ago - InvestorPlace

BNGO stock is a play on a potentially disruptive technology. But investors can't forget that most potentially disruptive technologies fail.

4 weeks ago - InvestorPlace

SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that multiple studies on the detection of structural variants using Bionano's optical genome mapping, ...

1 month ago - GlobeNewsWire

Is (BNGO) Outperforming Other Medical Stocks This Year?

1 month ago - Zacks Investment Research

Massive dilution, sluggish sales, and ballooning expenses will keep most away from BNGO stock despite its positive attributes. The post Bionano Will Eventually Return to Earth Due to Its Weak Fundamenta...

1 month ago - InvestorPlace

BNGO stock has been beaten down as of late, but it presents a great buying opportunity to invest in the emerging life sciences player. The post The Recent Pullback in Bionano Genomics Is a Major Buying ...

1 month ago - InvestorPlace

It may have the goods longer term, but a profitable position in BNGO stock in 2021 is tied to the price chart and maybe Ark Invest. The post This Is When Bionano Genomics Becomes a Buy appeared first on...

1 month ago - InvestorPlace

These stocks have been unstoppable since late December -- but will they stay that way?

Other stocks mentioned: GME, OCGN, SAVA, ZOM
1 month ago - The Motley Fool

Gene science will continue to drive the healthcare sector to new heights.

Other stocks mentioned: FLGT, ILMN
1 month ago - The Motley Fool

Bionano Genomics (BNGO) stock is on the rise Wednesday as investors react to news announced by the company after markets closed on Tuesday. The post BNGO Stock: 9 Reasons Why Bionano Genomics Shares Are...

1 month ago - InvestorPlace

The genomic analysis systems maker beat expectations and looks for a big jump in its installed base this year.

1 month ago - The Motley Fool

Shares of Bionano Genomics (NASDAQ:BNGO) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 82.61% year over year to ($0.04), which beat t...

1 month ago - Benzinga

-Solidified Financial Position Raising Approximately $335 Million in Q1 2021

1 month ago - GlobeNewsWire

Reddit penny stocks continue to be of interest to risky investors and InvestorPlace is looking at the top ones for Monday. The post 10 Reddit Penny Stocks Seeing the Most Chatter Today appeared first on...

Other stocks mentioned: AYTU, CTXR, DNN, HOFV, IDEX, MRKR, NEOS ...
1 month ago - InvestorPlace

A single study launched an epic rally in BNGO stock. But the company still has much to prove, and 3,400% gains don't price in the risks.

1 month ago - InvestorPlace

Bionano Genomics (NASDAQ:BNGO) announces its next round of earnings this Tuesday, March 23. Here is Benzinga's everything-that-matters guide for this Tuesday's Q4 earnings announcement.

1 month ago - Benzinga

BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.

1 month ago - InvestorPlace

Investors in BNGO stock have seen year-over-year stock price appreciation of more than 2,200%, but can it continue long-term? The post Valuation Not Meme Stock Status Should Worry You About Bionano Geno...

1 month ago - InvestorPlace

Several noteworthy names are making their earnings reports next week. Here are some of the most interesting ones for investors to watch.

Other stocks mentioned: ADBE, DRI, GIS, GME, GRWG, RH
1 month ago - InvestorPlace

While it doesn't get a lot of press, the Autism market is unfortunately a rapidly growing market opportunity. According to recent data from the CDC, roughly 2% of all kids are now diagnosed with Autism ...

Other stocks mentioned: ISWH, ZYNE
1 month ago - OTC PR Wire

Those investors bullish on genomics might want to analyze the Q4 results of BNGO stock The post BioNano Genomics Will Likely Be Volatile Prior to Q4 Earnings appeared first on InvestorPlace. More From I...

1 month ago - InvestorPlace

Technically, BNGO stock appeared on the verge of a robust breakout move but with shares tumbling instead, it's time to reassess the overall picture. The post BioNano Genomics Is an Excellent Lesson in T...

1 month ago - InvestorPlace

SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences:

1 month ago - GlobeNewsWire

In the latest trading session, Bionano Genomics, Inc. (BNGO) closed at $9.38, marking a -1.57% move from the previous day.

1 month ago - Zacks Investment Research

Bionano's Saphyr system looks poised to revolutionize diagnostics and medical research, making BNGO stock worth buying for long-term investors. The post Addressable Market Aside, Bionano Stock Is a Buy ...

1 month ago - InvestorPlace

SAN DIEGO, March 10, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management presented virtually at the H.C. Wainwright Global Life Sciences Conference, wh...

1 month ago - GlobeNewsWire

Bionano Genomics has a massive valuation based on recent capital raises. BNGO stock is fully valued at 108 times forward 2021 sales, even though sales may spike going forward.

1 month ago - InvestorPlace

SAN DIEGO, March 09, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 23rd, 2021 at 4:30 p.m. Eastern...

1 month ago - GlobeNewsWire

Investors need to pay close attention to Bionano Genomics (BNGO) stock based on the movements in the options market lately.

2 months ago - Zacks Investment Research

Bionano Genomics (BNGO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

2 months ago - Zacks Investment Research

BNGO stock is on the high side right now, especially since it will likely take time for the company's system to get traction. The post Lofty Expectations Are Already Priced Into Bionano Genomics appeare...

2 months ago - InvestorPlace

SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that Praxis Genomics, LLC received DEX Z-codes from Palmetto MolDX for its entire testing menu of labo...

2 months ago - GlobeNewsWire

BNGO stock shot up massively in the past few months. Now isn't the time to invest as the company must first prove its technology sells.

Other stocks mentioned: BNGOU
2 months ago - InvestorPlace

SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the Cowen 41st Annual Health Care Conference. Erik H...

2 months ago - GlobeNewsWire

Bionano Genomics, Inc. (BNGO) closed at $9.84 in the latest trading session, marking a +1.13% move from the prior day.

2 months ago - Zacks Investment Research

Without revenue growth, it's hard to be bullish on BNGO stock for the long-term The post It's Time to Take Profits on Volatile BioNano Genomics Stock and Buy It Back on Dips appeared first on InvestorPl...

2 months ago - InvestorPlace

SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the 2021 Advances in Genome Biology and Technology (AGBT) meeting will feature presentations from...

2 months ago - GlobeNewsWire

Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant calls Article published in Science reveals that optical genome mapping uniquely make...

2 months ago - GlobeNewsWire

About BNGO

Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes. Its Saphyr system includes an instrument, chip consumables, reagents, a suite of data analysis tools, and genome analysis services for researchers ... [Read more...]

Industry
Diagnostics & Research
IPO Date
Aug 21, 2018
CEO
R. Erik Holmlin
Employees
147
Stock Exchange
NASDAQ
Ticker Symbol
BNGO
Full Company Profile

Financial Performance

In 2020, BNGO's revenue was $8.50 million, a decrease of -16.06% compared to the previous year's $10.13 million. Losses were -$41.11 million, 37.9% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for BNGO stock is "Buy." The 12-month stock price forecast is 13.92, which is an increase of 157.30% from the latest price.

Price Target
$13.92
(157.30% upside)
Analyst Consensus: Buy